These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 18509785

  • 1. Eligen insulin--a system for the oral delivery of insulin for diabetes.
    Hoffman A, Qadri B.
    IDrugs; 2008 Jun; 11(6):433-41. PubMed ID: 18509785
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Insulin detemir. Novo Nordisk.
    Barlocco D.
    Curr Opin Investig Drugs; 2003 Apr; 4(4):449-54. PubMed ID: 12808886
    [Abstract] [Full Text] [Related]

  • 4. Nanoparticle strategies for the oral delivery of insulin.
    Damgé C, Reis CP, Maincent P.
    Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
    [Abstract] [Full Text] [Related]

  • 5. Inhaled insulin--does it become reality?
    Siekmeier R, Scheuch G.
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634
    [Abstract] [Full Text] [Related]

  • 6. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: clinical efficacy.
    Scherbaum WA.
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S9-13. PubMed ID: 16135137
    [Abstract] [Full Text] [Related]

  • 7. SomatoKine. Insmed.
    Norman P.
    Curr Opin Investig Drugs; 2003 Apr; 4(4):466-71. PubMed ID: 12808889
    [Abstract] [Full Text] [Related]

  • 8. Insulin glulisine. Aventis Pharma.
    Barlocco D.
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1240-4. PubMed ID: 14649217
    [Abstract] [Full Text] [Related]

  • 9. Pulmonary insulin delivery by means of the Technosphere drug carrier mechanism.
    Pfützner A, Forst T.
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1097-106. PubMed ID: 16296812
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Biotechnological and administration innovations in insulin therapy].
    Verge D.
    Med Sci (Paris); 2004 Nov; 20(11):986-98. PubMed ID: 15525494
    [Abstract] [Full Text] [Related]

  • 12. [Inhaled insulin: clinical results in type 2 diabetic patients].
    Selam JL.
    Diabetes Metab; 2001 Nov; 27(5 Pt 3):S28-32. PubMed ID: 11910977
    [Abstract] [Full Text] [Related]

  • 13. Insuline glusine (Apidra): a new rapid-acting insulin.
    Med Lett Drugs Ther; 2006 Apr 24; 48(1233):33-4. PubMed ID: 16625142
    [Abstract] [Full Text] [Related]

  • 14. Inhaled insulin: new technology, new possibilities.
    Bellary S, Barnett AH.
    Int J Clin Pract; 2006 Jun 24; 60(6):728-34. PubMed ID: 16805759
    [Abstract] [Full Text] [Related]

  • 15. Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
    Gallwitz B.
    IDrugs; 2008 Dec 24; 11(12):906-17. PubMed ID: 19051153
    [Abstract] [Full Text] [Related]

  • 16. Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery.
    Klonoff DC.
    Pediatr Endocrinol Rev; 2003 Dec 24; 1(2):94-100. PubMed ID: 16437014
    [Abstract] [Full Text] [Related]

  • 17. U-500 insulin: why, when and how to use in clinical practice.
    Garg R, Johnston V, McNally PG, Davies MJ, Lawrence IG.
    Diabetes Metab Res Rev; 2007 May 24; 23(4):265-8. PubMed ID: 17109474
    [Abstract] [Full Text] [Related]

  • 18. [Intensive insulin therapy: results after ten years].
    Laube H.
    Pharm Unserer Zeit; 2001 Jan 24; 30(1):40-5. PubMed ID: 11233182
    [No Abstract] [Full Text] [Related]

  • 19. Drug therapy for diabetes.
    Haas LB.
    Nurse Pract Forum; 1991 Sep 24; 2(3):166-74. PubMed ID: 1840969
    [Abstract] [Full Text] [Related]

  • 20. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: safety.
    Brain JD.
    Diabetes Obes Metab; 2005 Nov 24; 7 Suppl 1():S14-8. PubMed ID: 16135134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.